A Novel Flex-Stretch-Flow Bioreactor for the Study of Engineered Heart Valve Tissue Mechanobiology
- 6 February 2008
- journal article
- research article
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 36 (5) , 700-712
- https://doi.org/10.1007/s10439-008-9447-6
Abstract
Tissue engineered heart valves (TEHV) have been observed to respond to mechanical conditioning in vitro by expression of activated myofibroblast phenotypes followed by improvements in tissue maturation. In separate studies, cyclic flexure, stretch, and flow (FSF) have been demonstrated to exhibit both independent and coupled stimulatory effects. Synthesis of these observations into a rational framework for TEHV mechanical conditioning has been limited, however, due to the functional complexity of tri-leaflet valves and the inherent differences of separate bioreactor systems. Toward quantifying the effects of individual mechanical stimuli similar to those that occur during normal valve function, a novel bioreactor was developed in which FSF mechanical stimuli can be applied to engineered heart valve tissues independently or in combination. The FSF bioreactor consists of two identically equipped chambers, each having the capacity to hold up to 12 rectangular tissue specimens (25 × 7.5 × 1 mm) via a novel “spiral-bound” technique. Specimens can be subjected to changes-in-curvature up to 50 mm−1 and uniaxial tensile strains up to 75%. Steady laminar flow can be applied by a magnetically coupled paddlewheel system. Computational fluid dynamic (CFD) simulations were conducted and experimentally validated by particle image velocimetry (PIV). Tissue specimen wall shear stress profiles were predicted as a function of paddlewheel speed, culture medium viscosity, and the quasi-static state of specimen deformation (i.e., either undeformed or completely flexed). Velocity profiles predicted by 2D CFD simulations of the paddlewheel mechanism compared well with PIV measurements, and were used to determine boundary conditions in localized 3D simulations. For undeformed specimens, predicted inter-specimen variations in wall shear stress were on average ±7%, with an average wall shear stress of 1.145 dyne/cm2 predicted at a paddlewheel speed of 2000 rpm and standard culture conditions. In contrast, while the average wall shear stress predicted for specimens in the quasi-static flexed state was ∼59% higher (1.821 dyne/cm2), flexed specimens exhibited a broad intra-specimen wall shear stress distribution between the convex and concave sides that correlated with specimen curvature, with peak wall shear stresses of ∼10 dyne/cm2. This result suggests that by utilizing simple flexed geometric configurations, the present system can also be used to study the effects of spatially varying shear stresses. We conclude that the present design provides a robust tool for the study of mechanical stimuli on in vitro engineered heart valve tissue formation.Keywords
This publication has 23 references indexed in Scilit:
- Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissuesBiomaterials, 2006
- Tissue Engineering of Human Heart Valve Leaflets: A Novel Bioreactor for a Strain-Based Conditioning ApproachAnnals of Biomedical Engineering, 2005
- From Stem Cells to Viable Autologous Semilunar Heart ValveCirculation, 2005
- The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissueBiomaterials, 2005
- Effects of Basic Fibroblast Growth Factor and Transforming Growth Factor-β on Maturation of Human Pediatric Aortic Cell Culture for Tissue Engineering of Cardiovascular StructuresAsaio Journal, 2004
- Creating Alignment and Anisotropy in Engineered Heart Tissue: Role of Boundary Conditions in a Model Three-Dimensional Culture SystemTissue Engineering, 2003
- Tissue Engineering Therapy for Cardiovascular DiseaseCirculation Research, 2003
- The Relevance of Large Strains in Functional Tissue Engineering of Heart ValvesThe Thoracic and Cardiovascular Surgeon, 2003
- New Pulsatile Bioreactor forIn VitroFormation of Tissue Engineered Heart ValvesTissue Engineering, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999